Delirium prevention trial for the patients admitted in acute care ward

Delirium prevention trial for the patients admitted in acute care ward - Delirium prevention in acute care ward

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030104

Enrollment

100

Registered

2017-11-24

Start date

2016-12-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

delirium

Interventions

Nursing intervention to prevent delirium, from Day 1 to Day 5 of admission Nursing intervention to prevent delirium, and taking 8 mg ramelteon at bedtime, from Day 1 to Day 5 of admission. Nursing int

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Delirium high risk patient

Exclusion criteria

Exclusion criteria: Delirious patients on admission Patients with contraindication of ramelteon or suvorexant Patients who took ramelteon or suvorexant on admission

Design outcomes

Primary

Measure	Time frame
Incidence of delirium which is judged by Japanese version of Intensive Care Delirium Screening Checklist (ICDSC) score from Day 1 to Day 5 of admission.	—

Secondary

Measure	Time frame
Nursing education effect on delirium in acure care ward.	—

Countries

Japan

Contacts

Public ContactEriko Sugawara

Yokohama Brain and Spine Center Department of Neurology

er01-sugawara@city.yokohama.jp045-753-2500

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026